St. Jude
Gates Foundation Awards Multiple Dx, Omics Grants in August and September
Awardees include Imperial College London, the Africa Health Research Institute, Mylab, CHOP, and the Task Force for Global Health, among others.
BioSkryb, St. Jude Expand Licensing Deal for Dx Applications of Single-Cell Tech
BioSkryb will now have an exclusive global license for clinical applications of primary template directed amplification technology.
Blood-Based Sequencing Test Identifies Pediatric Cancer Infections Before Symptoms
St. Jude Children's Research Hospital researchers evaluated a microbial cell-free DNA sequencing test from infectious disease diagnostics firm Karius.
St. Jude Children's Research Hospital, RPRD Diagnostics Partner to Offer Pharmacogenetic Testing
Right Patient Right Drug will use the PharmacoScan platform to perform preventive pharmacogenetic testing under St. Jude's PG4KDS program.